Previous Events

From Postdocs to Innovators with Chris and Pamela Contag:
Co-Founders of Xenogen

Event Date: Wednesday, March 16, 2011 , 5:45 pm to 7:30 pm
Location: Clark Center, room S360 (Behind Peet's Coffee)
Funding for the event is generously provided by the Stanford Office of Technology Licensing (OTL)

Profile of Chris and Pamela Contag
Co-Founders of Xenogen - From Postdocs to Innovators

This AIMS event explores innovation in academia, and the bridge between industry and the academia.

Chris and Pamela Contag are a husband and wife team, both former Stanford postdocs. In 1995, they co-founded Xenogen - a life science startup that created an in vivo imaging system with advanced fluorescent detection capability to accelerate preclinical drug discovery and development. In 2006, Xenogen was acquired by Caliper Life Science.

After Xenogen, Christopher Contag became assistant professor of Pediatrics at Stanford University. He is now an Associate Professor of Pediatrics and the Co-Director of the Molecular Imaging Program at Stanford (MIPS). MIPS is an inter-disciplinary program that brings together scientists and physicians who share a common interest in developing and using state-of-the-art imaging technology and developing molecular imaging assays for studying intact biological systems.

In contrast, Pamela Contag became a serial entrepreneur. Pam founded a slew of life-science startups (ConcentRx, Cygnet BioFuels), of which she was also the CEO (Cobalt Biofuels, ConcentRx). She is now the owner of Cygnet Biofuels – an integrated energy system start-up.

Chris and Pam have kindly agreed to share their valuable time and insights on what it takes to be a Postdoc entrepreneur.